BioXcel Therapeutics Inc. (BTAI) 股价在盘前交易中大幅上涨21.1%,此前该公司宣布其用于治疗阿片类药物戒断的实验性药物在一项中期临床试验中显示出积极疗效。这一积极数据显著提振了投资者信心,推动该公司股价强势上扬。
BioXcel Therapeutics Inc. (BTAI) 股价在盘前交易中大幅上涨21.1%,此前该公司宣布其用于治疗阿片类药物戒断的实验性药物在一项中期临床试验中显示出积极疗效。这一积极数据显著提振了投资者信心,推动该公司股价强势上扬。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.